Prener Anne 4
4 · Kaleido Biosciences, Inc. · Filed Apr 3, 2020
Insider Transaction Report
Form 4
Prener Anne
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-01+30,000→ 30,000 totalExercise: $5.21Exp: 2030-04-01→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Thirty three percent of this option shall vest on April 1, 2021, with the remainder vesting in two equal annual installments thereafter, subject to Dr. Prener's continued service on the board of directors through each such date. This grant was made in accordance with the Company's Non-Employee Director Compensation Policy.